BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Bank of America Merrill Lynch
|Closed|| Long (1Y)
Bank of America Merrill Lynch maintains buy on Sun Pharma
Bank of America Merrill Lynch has maintained its buy call on Sun Pharma on the back of attractive valuations. However, it prefers Lupin over Sun Pharma. It adds that Odomzo acquisition will strengthen specialty portfolio. Meanwhile, the brokerage does not see a re-rating on Sun Pharma in the near-term.